Ikena Oncology, Inc.·4

Dec 23, 6:43 PM ET

FORMELA JEAN FRANCOIS 4

4 · Ikena Oncology, Inc. · Filed Dec 23, 2021

Insider Transaction Report

Form 4
Period: 2021-12-21
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-21+13,41913,419 total
    Exercise: $14.92Exp: 2031-12-21Common Stock (13,419 underlying)
Footnotes (2)
  • [F1]This option shall vest (1) 25% on December 21, 2022, and the remaining shall vest in equal monthly installments over the next 36 months.
  • [F2]This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION